Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Multinational Postmarketing Observational Study of Women Prescribed Intrinsa.

Trial Profile

The Multinational Postmarketing Observational Study of Women Prescribed Intrinsa.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 31 Mar 2015

At a glance

  • Drugs Estrogen; Testosterone
  • Indications Female sexual dysfunction; Hormone deficiency
  • Focus Adverse reactions
  • Acronyms EMPOWER
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 27 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 Jun 2012 as reported by ClinicalTrials.gov record.
    • 01 Nov 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top